Therefore, ANXA8, which is associated with these immune molecules, may provide a new target for studying the immune evasion of ovarian cancer cells and can potentially serve as a immunotherapeutic target for ovarian cancer. This evidence concerns the gene ANXA8 and ovarian cancer.